Day: April 10, 2023

PLEASANTON, Calif., April 10, 2023 (GLOBE NEWSWIRE) — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today announced the closing of a private placement of 769,231 shares of its common stock for a purchase price of $0.65 per share, generating aggregate gross proceeds to the Company of $500,000. Net proceeds from the sale of the securities will be used for working capital purposes.  “This cash infusion will support our continuous innovation and development of tools that reinforce healthcare progress through digital transformation,” said Thyagarajan Ramachandran, Chief Financial Officer of Healthcare Triangle. “We appreciate the vote of confidence...

Neve Yarak, Israel, April 10, 2023 (GLOBE NEWSWIRE) — Save Foods, Inc. (NASDAQ: SVFD) (FSE:80W) (“Save Foods” or the “Company”), an agri-food tech company specializing in eco-crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, today announces that it has acquired (the “Acquisition”) direct ownership of common shares (“Common Shares”) in the capital of Plantify Foods, Inc. (“Plantify”) in the amount of 30,004,349 Common Shares, a company with its head office located at 2264 East 11th Avenue, Vancouver, British Columbia, V5N 1Z6, and whose Common Shares trade on the TSX Venture Exchange under the symbol “PTFY”, at a purchase price of CAD$0.05 per Common Share, which were acquired in exchange for 1,164,374 shares of common stock of Save Foods. The Acquisition was completed pursuant...

BONITA SPRINGS, Fla., April 10, 2023 (GLOBE NEWSWIRE) — Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH” or the “Company”), a national seller of gourmet specialty foods to professional and home chefs today released the following letter from the Chief Executive Officer to Shareholders. Dear Fellow Shareholders, With just a few weeks under my belt, it is thrilling to write my first letter to our shareholders. As you may know, I joined IVFH as CEO on February 28, 2023, after an extensive career at several Fortune 500 food, consumer, and retail companies. Most recently, I led eCommerce for The Kroger Co., responsible for Kroger’s $10 billion eCommerce business. I am honored to have the opportunity to serve IVFH as CEO and leverage my background, network, and leadership experience to take IVFH to the next level. I am excited by...

ROGERS, Ark., April 10, 2023 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) has been named to Newsweek’s “Most Trustworthy Companies in America 2023” list. Car-Mart is one of 700 companies across 23 industries earning this distinction. The ranking is a listing of top companies who were chosen based on a holistic approach to evaluating trust. “For over four decades, America’s Car-Mart has been a trusted leader in our industry, and we are honored to be recognized as one of the most trustworthy companies in America,” said Jeff Williams, Chief Executive Officer. “In any business, there’s no higher honor than to earn the trust of our customers. This only happens with a culture of integrity and our enduring commitment to doing the right thing. “We are incredibly grateful to our associates who go to work every day to serve...

BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced that David Meeker, M.D., Chair, Chief Executive Officer and President, will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2023 at 3:00 p.m. ET. A live audio webcast of the presentation will be available under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com. A replay of the webcast will be available on the Rhythm website for 30 days following the presentation. About Rhythm PharmaceuticalsRhythm...

NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a  biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that management will present at the 22nd Annual Needham Virtual Healthcare Conference on April 17, 2023 at 11:00 a.m. ET. A live webcast of the presentation can be accessed through the Events & Presentations section of the Company’s website at investors.ovidrx.com. An archived replay of the webcast will be available on the Company’s website following the live presentation. About Ovid TherapeuticsOvid Therapeutics Inc. is a New York-based biopharmaceutical company striving to conquer seizures and brain disorders with courageous science. Ovid’s pipeline of small molecule and genetic medicines...

VANCOUVER, British Columbia, April 10, 2023 (GLOBE NEWSWIRE) — Amcomri Entertainment Inc. (“Amcomri” or the “Company”) (NEO: AMEN) (OTC: AMNNF) (Frankfurt: 25YO) announces that further to its press release dated April 3, 2023, the British Columbia Securities Commission (the “BCSC”) and the Ontario Securities Commission (the “OSC”), issued a failure-to-file cease trade order (a “FFCTO”) against the Company as a result of the Company’s failure to file, on or before March 31, 2023, its audited financial statements, management discussion & analysis, annual information form, and related officer certifications for the year ended December 31, 2022 (collectively, the “Required Filings”). Every effort is being made by the Company to complete the Required Filings as soon as possible and the Company believes that it will be able to complete...

Dundee Corporation to further streamline its capital structure and return cash to shareholders TORONTO, April 10, 2023 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A, DC.PR.B, DC.PR.D) (“Dundee” or the “Company”) announced today receipt of regulatory approval for its notice of intention to renew its normal course issuer bids (“Bids”) in respect of its class A subordinate voting shares (“Class A Shares”), cumulative 5-year rate reset first preference shares, series 2 (“Series 2 Shares”) and cumulative floating rate first preference shares, series 3 (“Series 3 Shares”), and collectively with Class A Shares and Series 2 Shares, the (“Securities”) through the facilities of the Toronto Stock Exchange (“TSX”) or alternative Canadian trading systems from April 12, 2023 to April 11, 2024. Jonathan Goodman, President and CEO of Dundee...